Bioartificial Organs II: Technology, Medicine, and Materials, Volume 875
New York Academy of Sciences, 1999 - Medical - 415 pages
The presentations in this volume, resulting from the 2nd International Conference on Bioartificial Organs, are divided almost equally among medical practitioners and surgeons, materials scientists and engineers; presenters came from industry, academia and governmental organizations. Sections are dedicated to specific diseases and organ replacements, such as the bioartificial pancreas (diabetes). Clinical trials on the bioartificial liver and skin are presented as are new developments in the craniofacial and cartilage areas. There is discussion on tissue sourcing (xeno-and allografts) as well as on the suitability of the proposed xenotransplantation for immunoisolation devices. Advances in genetically modified cells are also highlighted. Sessions on the molecular aspects of rejection prevention, on new biomaterials, and on processing complement the plenary medical- and technology-oriented themes. A panel discussion on scale-up and commercial implementation rounds out the volume.
25 pages matching donor in this book
Results 1-3 of 25
What people are saying - Write a review
We haven't found any reviews in the usual places.
Control of Complement Activities for Immunoisolation By HIROO IWATA
Designing Biomaterials to Direct Biological Responses By KEVIN E HEALY
New Microcapsules Based on Oligoelectrolyte Complexation By ARTUR
27 other sections not shown
acid activation adhesion alginate allogeneic allografts animals antibodies antigen Artif artificial B-cell beads bioartificial liver bioartificial organs bioreactor Biotechnol blood BLSS bone capsules cartilage cell line chitosan chondrocytes collagen complement cryopreserved culture cytokines device diabetes diffusion donor encapsulated cells encapsulated islet enzyme extracorporeal factor FIGURE function gene therapy genetically engineered glucose graft growth hepatic failure hepatocytes hollow fiber hydrogel immobilization immune immunoisolation immunosuppression implanted incubation insulin insulin secretion islet cells islet transplantation islet xenografts islets of Langerhans isolation layer liver failure liver support medium membrane metabolic microbead microcapsules molar mass molecular molecules NOD mice oxygen pancreatic pancreatic islet pathway patients peptide perfusion plasma polymer porcine islets potential Proc production protein PSSa RAJOTTE reaction recipients response rhBMP-2 serum solution sponges studies surface survival tion tissue engineering transgenic treatment viability vitro vivo xenogeneic xenograft rejection xenografts xenotransplantation